MedPath

ELIMINATION OF CYSTICERCOSIS IN PER

Phase 1
Conditions
Taeniasis
-B68 Taeniasis-B690 Cysticercosis of central nervous system
Cysticercosis of central nervous system
B68
B690
Registration Number
PER-002-05
Lead Sponsor
BILL & MELINDA GATES FOUNDATION,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Not specified
Target Recruitment
103554
Inclusion Criteria

- Resident of the rural areas of Tumbes, Talara and Sullana (who stays at least two nights in the
community)
- Resident over two years.

Exclusion Criteria

- Residents who refuse to participate in the study.
- Women in gestation will not receive massive treatment of niclosamide.
- Participants with a history of adverse effects to nidosamide will not participate in the mass treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br>Outcome name:Application of 6 different models for the control of taeniasis in human and porcine population. After this the 2 most successful models of intervention are applied at large scale<br>Measure:Development and evaluation of a new control strategy for the treatment of taeniasis and human and porcine neurocysticercosis<br>Timepoints:48 months<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath